The limited presence of GRP78 on the surface of tumor cells makes it an interesting target in the field of cancer-related antibody research and treatment since it could potentially have a significant effect on the fight against cancer [95], with the potential for advancing to the next stage in the development of cancer immunotherapy. The gene discussed is HSPA5; the disease is neoplasm.